IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-30496-0.html
   My bibliography  Save this article

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Author

Listed:
  • Mrinal M. Gounder

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Narasimhan P. Agaram

    (Memorial Sloan Kettering Cancer Center)

  • Sally E. Trabucco

    (Foundation Medicine, Inc.)

  • Victoria Robinson

    (Memorial Sloan Kettering Cancer Center)

  • Richard A. Ferraro

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Sherri Z. Millis

    (Foundation Medicine, Inc.)

  • Anita Krishnan

    (Memorial Sloan Kettering Cancer Center)

  • Jessica Lee

    (Foundation Medicine, Inc.)

  • Steven Attia

    (Mayo Clinic)

  • Wassim Abida

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Alexander Drilon

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Ping Chi

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Sandra P. D’ Angelo

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Mark A. Dickson

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Mary Lou Keohan

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Ciara M. Kelly

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Mark Agulnik

    (City of Hope)

  • Sant P. Chawla

    (Sarcoma Center of Santa Monica)

  • Edwin Choy

    (Massachusetts General Hospital
    Harvard Medical School)

  • Rashmi Chugh

    (University of Michigan)

  • Christian F. Meyer

    (Johns Hopkins Sidney Kimmel Comprehensive Center)

  • Parvathi A. Myer

    (Albert Einstein College of Medicine)

  • Jessica L. Moore

    (Memorial Sloan Kettering Cancer Center)

  • Ross A. Okimoto

    (University of California at San Francisco)

  • Raphael E. Pollock

    (Ohio State University)

  • Vinod Ravi

    (The University of Texas MD Anderson Cancer Center)

  • Arun S. Singh

    (University of California at Los Angeles)

  • Neeta Somaiah

    (The University of Texas MD Anderson Cancer Center)

  • Andrew J. Wagner

    (Harvard Medical School
    Dana-Farber Cancer Institute)

  • John H. Healey

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Garrett M. Frampton

    (Foundation Medicine, Inc.)

  • Jeffrey M. Venstrom

    (Foundation Medicine, Inc.)

  • Jeffrey S. Ross

    (Foundation Medicine, Inc.
    Albany Medical College)

  • Marc Ladanyi

    (Memorial Sloan Kettering Cancer Center)

  • Samuel Singer

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Murray F. Brennan

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Gary K. Schwartz

    (Columbia University)

  • Alexander J. Lazar

    (Ohio State University)

  • David M. Thomas

    (Garvan Institute of Medical Research)

  • Robert G. Maki

    (University of Pennsylvania)

  • William D. Tap

    (Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical College)

  • Siraj M. Ali

    (Foundation Medicine, Inc.)

  • Dexter X. Jin

    (Foundation Medicine, Inc.)

Abstract

There are more than 70 distinct sarcomas, and this diversity complicates the development of precision-based therapeutics for these cancers. Prospective comprehensive genomic profiling could overcome this challenge by providing insight into sarcomas’ molecular drivers. Through targeted panel sequencing of 7494 sarcomas representing 44 histologies, we identify highly recurrent and type-specific alterations that aid in diagnosis and treatment decisions. Sequencing could lead to refinement or reassignment of 10.5% of diagnoses. Nearly one-third of patients (31.7%) harbor potentially actionable alterations, including a significant proportion (2.6%) with kinase gene rearrangements; 3.9% have a tumor mutational burden ≥10 mut/Mb. We describe low frequencies of microsatellite instability (

Suggested Citation

  • Mrinal M. Gounder & Narasimhan P. Agaram & Sally E. Trabucco & Victoria Robinson & Richard A. Ferraro & Sherri Z. Millis & Anita Krishnan & Jessica Lee & Steven Attia & Wassim Abida & Alexander Drilon, 2022. "Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30496-0
    DOI: 10.1038/s41467-022-30496-0
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-30496-0
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-022-30496-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Nicolas Stransky & Ethan Cerami & Stefanie Schalm & Joseph L. Kim & Christoph Lengauer, 2014. "The landscape of kinase fusions in cancer," Nature Communications, Nature, vol. 5(1), pages 1-10, December.
    2. Ludmil B. Alexandrov & Serena Nik-Zainal & David C. Wedge & Samuel A. J. R. Aparicio & Sam Behjati & Andrew V. Biankin & Graham R. Bignell & Niccolò Bolli & Ake Borg & Anne-Lise Børresen-Dale & Sandri, 2013. "Correction: Corrigendum: Signatures of mutational processes in human cancer," Nature, Nature, vol. 502(7470), pages 258-258, October.
    3. Priya Chudasama & Sadaf S. Mughal & Mathijs A. Sanders & Daniel Hübschmann & Inn Chung & Katharina I. Deeg & Siao-Han Wong & Sophie Rabe & Mario Hlevnjak & Marc Zapatka & Aurélie Ernst & Kortine Klein, 2018. "Integrative genomic and transcriptomic analysis of leiomyosarcoma," Nature Communications, Nature, vol. 9(1), pages 1-15, December.
    4. Philip Jonsson & Chaitanya Bandlamudi & Michael L. Cheng & Preethi Srinivasan & Shweta S. Chavan & Noah D. Friedman & Ezra Y. Rosen & Allison L. Richards & Nancy Bouvier & S. Duygu Selcuklu & Craig M., 2019. "Tumour lineage shapes BRCA-mediated phenotypes," Nature, Nature, vol. 571(7766), pages 576-579, July.
    5. Joonil Jung & Joon Sang Lee & Mark A. Dickson & Gary K. Schwartz & Axel Le Cesne & Andrea Varga & Rastilav Bahleda & Andrew J. Wagner & Edwin Choy & Maja J. de Jonge & Madelyn Light & Steve Rowley & S, 2016. "TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma," Nature Communications, Nature, vol. 7(1), pages 1-7, November.
    6. Ludmil B. Alexandrov & Serena Nik-Zainal & David C. Wedge & Samuel A. J. R. Aparicio & Sam Behjati & Andrew V. Biankin & Graham R. Bignell & Niccolò Bolli & Ake Borg & Anne-Lise Børresen-Dale & Sandri, 2013. "Signatures of mutational processes in human cancer," Nature, Nature, vol. 500(7463), pages 415-421, August.
    7. Stefan Gröschel & Daniel Hübschmann & Francesco Raimondi & Peter Horak & Gregor Warsow & Martina Fröhlich & Barbara Klink & Laura Gieldon & Barbara Hutter & Kortine Kleinheinz & David Bonekamp & Olive, 2019. "Defective homologous recombination DNA repair as therapeutic target in advanced chordoma," Nature Communications, Nature, vol. 10(1), pages 1-9, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ezra Y. Rosen & Helen H. Won & Youyun Zheng & Emiliano Cocco & Duygu Selcuklu & Yixiao Gong & Noah D. Friedman & Ino Bruijn & Onur Sumer & Craig M. Bielski & Casey Savin & Caitlin Bourque & Christina , 2022. "The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers," Nature Communications, Nature, vol. 13(1), pages 1-9, December.
    2. Yonina R. Murciano-Goroff & Alison M. Schram & Ezra Y. Rosen & Helen Won & Yixiao Gong & Anne Marie Noronha & Yelena Y. Janjigian & Zsofia K. Stadler & Jason C. Chang & Soo-Ryum Yang & Diana Mandelker, 2022. "Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    3. Mischan Vali-Pour & Solip Park & Jose Espinosa-Carrasco & Daniel Ortiz-Martínez & Ben Lehner & Fran Supek, 2022. "The impact of rare germline variants on human somatic mutation processes," Nature Communications, Nature, vol. 13(1), pages 1-21, December.
    4. Jennifer B. Shah & Dana Pueschl & Bradley Wubbenhorst & Mengyao Fan & John Pluta & Kurt D’Andrea & Anna P. Hubert & Jake S. Shilan & Wenting Zhou & Adam A. Kraya & Alba Llop Guevara & Catherine Ruan &, 2022. "Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    5. Jurica Levatić & Marina Salvadores & Francisco Fuster-Tormo & Fran Supek, 2022. "Mutational signatures are markers of drug sensitivity of cancer cells," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    6. Xing Cheng & Jing An & Jitong Lou & Qisheng Gu & Weimin Ding & Gaith Nabil Droby & Yilin Wang & Chenghao Wang & Yanzhe Gao & Jay Ramanlal Anand & Abigail Shelton & Andrew Benson Satterlee & Breanna Ma, 2024. "Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    7. Michelle Dietzen & Haoran Zhai & Olivia Lucas & Oriol Pich & Christopher Barrington & Wei-Ting Lu & Sophia Ward & Yanping Guo & Robert E. Hynds & Simone Zaccaria & Charles Swanton & Nicholas McGranaha, 2024. "Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution," Nature Communications, Nature, vol. 15(1), pages 1-23, December.
    8. Anna Luiza Silva Almeida Vicente & Alexei Novoloaca & Vincent Cahais & Zainab Awada & Cyrille Cuenin & Natália Spitz & André Lopes Carvalho & Adriane Feijó Evangelista & Camila Souza Crovador & Rui Ma, 2022. "Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    9. Teresa Maria Rosaria Noviello & Anna Maria Giacomo & Francesca Pia Caruso & Alessia Covre & Roberta Mortarini & Giovanni Scala & Maria Claudia Costa & Sandra Coral & Wolf H. Fridman & Catherine Sautès, 2023. "Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    10. Qi Zhao & Feng Wang & Yan-Xing Chen & Shifu Chen & Yi-Chen Yao & Zhao-Lei Zeng & Teng-Jia Jiang & Ying-Nan Wang & Chen-Yi Wu & Ying Jing & You-Sheng Huang & Jing Zhang & Zi-Xian Wang & Ming-Ming He & , 2022. "Comprehensive profiling of 1015 patients’ exomes reveals genomic-clinical associations in colorectal cancer," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    11. Rebecca J. Austin & Jasmin Straube & Rohit Halder & Yashaswini Janardhanan & Claudia Bruedigam & Matthew Witkowski & Leanne Cooper & Amy Porter & Matthias Braun & Fernando Souza-Fonseca-Guimaraes & Si, 2023. "Oncogenic drivers dictate immune control of acute myeloid leukemia," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    12. David Wang & Mathieu Quesnel-Vallieres & San Jewell & Moein Elzubeir & Kristen Lynch & Andrei Thomas-Tikhonenko & Yoseph Barash, 2023. "A Bayesian model for unsupervised detection of RNA splicing based subtypes in cancers," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    13. Saptarshi Chakraborty & Colin B. Begg & Ronglai Shen, 2021. "Using the “Hidden” genome to improve classification of cancer types," Biometrics, The International Biometric Society, vol. 77(4), pages 1445-1455, December.
    14. Caralyn Reisle & Laura M. Williamson & Erin Pleasance & Anna Davies & Brayden Pellegrini & Dustin W. Bleile & Karen L. Mungall & Eric Chuah & Martin R. Jones & Yussanne Ma & Eleanor Lewis & Isaac Beck, 2022. "A platform for oncogenomic reporting and interpretation," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    15. Kathiresan Selvam & Smitha Sivapragasam & Gregory M. K. Poon & John J. Wyrick, 2023. "Detecting recurrent passenger mutations in melanoma by targeted UV damage sequencing," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    16. Antonio Rodriguez-Calero & John Gallon & Dilara Akhoundova & Sina Maletti & Alison Ferguson & Joanna Cyrta & Ursula Amstutz & Andrea Garofoli & Viola Paradiso & Scott A. Tomlins & Ekkehard Hewer & Ver, 2022. "Alterations in homologous recombination repair genes in prostate cancer brain metastases," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    17. Se Jin Park & Gwan Woo Ku & Su Yel Lee & Daeun Kang & Wan Jin Hwang & In Beom Jeong & Sun Jung Kwon & Jaeku Kang & Ji Woong Son, 2021. "Analysis of Single Nucleotide Variants (SNVs) Induced by Exposure to PM 10 in Lung Epithelial Cells Using Whole Genome Sequencing," IJERPH, MDPI, vol. 18(3), pages 1-11, January.
    18. Ming Tang & Hussein A. Abbas & Marcelo V. Negrao & Maheshwari Ramineni & Xin Hu & Shawna Marie Hubert & Junya Fujimoto & Alexandre Reuben & Susan Varghese & Jianhua Zhang & Jun Li & Chi-Wan Chow & Xiz, 2021. "The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    19. Wenying Peng & Bin Li & Jin Li & Lianpeng Chang & Jing Bai & Yuting Yi & Rongrong Chen & Yanyan Zhang & Chen Chen & Xingxiang Pu & Meilin Jiang & Jia Li & Rui Zhong & Fang Xu & Bolin Chen & Li Xu & Ni, 2022. "Clinical and genomic features of Chinese lung cancer patients with germline mutations," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    20. Sijia Cui & Nicholas McGranahan & Jing Gao & Peng Chen & Wei Jiang & Lingrong Yang & Li Ma & Junfang Liao & Tian Xie & Congying Xie & Tariq Enver & Shixiu Wu, 2023. "Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing," Nature Communications, Nature, vol. 14(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30496-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.